Success for integrated cancer care teams rely on a few things, such as having a champion, commitment, and strong communication, explained Thomas Asfeldt, MBA, RN, director of Outpatient Cancer Services at Sanford Cancer Center.
Success for integrated cancer care teams rely on a few things, such as having a champion, commitment, and strong communication, explained Thomas Asfeldt, MBA, RN, director of Outpatient Cancer Services at Sanford Cancer Center.
Transcript
What are the best practices that help create integrated care teams in cancer?
The 2 biggest things that I’ve seen, certainly in our program and in talking with others, is: do you have a champion? And are you committed?
When you start an integrated care team—and I’ll just use a tumor site—say you want to start an integrated care team for lung cancer patients, and if you have a physician champion—you really need to have a physician champion for an integrated care team—if you have that champion, it doesn’t have to be the person who has been there the longest or has the longest CV, but it’s a person that really has the passion for that integrated care team. That’s the number 1 thing I think you have to have. That’s a best practice. And that might be someone who has come forward and said, “I want to build this” or “I want to be part of building this; how can we do that?” It might be someone you see that has the personality or the right panache to do that, and you’re showing them the benefits of that for your program, and so together you work to identify that person as the champion.
And then it’s the commitment. It’s the commitment of your entire healthcare team. It’s the commitment of your administration to say, “Yes, this is what we want to be as an integrated healthcare system and delivering care to our patients.” So, it’s having that champion on board and having the commitment of your team, I think, are the 2 most important best practices in building it.
And then it’s jumping in and getting it down. Because it does take some time.
How can integrated care teams prevent a communication breakdown?
Communicate, communicate, communicate. Document, document, document. And whatever the communication looks like, that might mean that you get together and have a morning huddle, if that’s what works best for your system. It might mean that you are providing lunch every day, so everyone gathers informally and talks about what’s going together with your system. The scale of your organization is going to impact how you do that right. If you’re 1 or 2 physicians with 4 or 5 supporting personnel, you can do that differently than if you’re an astronomic organization.
The thing that’s going to be really important for communication is making sure that you’re documenting the recommendations that the integrated team puts together in the EMR [electronic medical record] so that whether you’re the provider that’s taking care of the patient specifically or if the primary care provider who is seeing them on an outpatient basis for their runny nose or their sore back that you also know what the plan of care is for the patient. What was discussed by the care team that’s taking care of their cancer?
So, document, document, document. Communicate, communicate, communicate. And make sure you put it in the record so everyone knows what the plan of care is for the integrated cancer care team.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More